Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
35
AMRN Quote, Financials, Valuation and Earnings
Last price:
$10.19
Seasonality move
:
-11.41%
Day range:
$10.18 - $10.77
52-week range:
$7.08 - $20.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.95x
P/B ratio:
0.45x
Volume:
77.9K
Avg. volume:
99.7K
1-year change:
-48.01%
Market cap:
$219.5M
Revenue:
$228.6M
EPS (TTM):
-$0.20
Analysts' Opinion
-
Consensus RatingAmarin Corp PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.50, Amarin Corp PLC has an estimated upside of 27.36% from its current price of $10.19.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $10.19.
Fair Value
-
According to the consensus of 1 analyst, Amarin Corp PLC has 27.36% upside to fair value with a price target of $13.50 per share.
AMRN vs. S&P 500
-
Over the past 5 trading days, Amarin Corp PLC has overperformed the S&P 500 by 1.24% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Amarin Corp PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Amarin Corp PLC revenues have been falling on a year-over-year basis for 14 quarters in a row. In the most recent quarter Amarin Corp PLC reported revenues of $62.3M.
Earnings Growth
-
Amarin Corp PLC earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Amarin Corp PLC reported earnings per share of -$0.12.
Enterprise value:
-74.7M
EV / Invested capital:
--
Price / LTM sales:
0.95x
EV / EBIT:
--
EV / Revenue:
-0.33x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
2.41x
Price / Operating cash flow:
266.49x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$81.4M
Return On Assets:
-10.65%
Net Income Margin (TTM):
-35.95%
Return On Equity:
-15.41%
Return On Invested Capital:
-15.41%
Operating Margin:
-84.3%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $369.2M | $306.9M | $228.6M | $74.7M | $62.3M | |
| Gross Profit | $242.5M | $165.5M | $81.4M | $45.1M | -$9.6M | |
| Operating Income | -$92.3M | -$56.6M | -$91.8M | -$4.6M | -$52.5M | |
| EBITDA | -$100.7M | -$50.7M | -$74.2M | -$920K | -$37.2M | |
| Diluted EPS | -$5.36 | -$3.00 | -$3.93 | -$0.40 | -$2.40 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $879.2M | $878.7M | $689.1M | $725M | $595.4M | |
| Total Assets | $966M | $1.1B | $886.2M | $831.7M | $685.3M | |
| Current Liabilities | $307.4M | $370.7M | $259.5M | $259.3M | $179.9M | |
| Total Liabilities | $338.5M | $401M | $290.8M | $279.6M | $199.2M | |
| Total Equity | $627.5M | $667.1M | $595.3M | $552.1M | $486.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$180.1M | $6.9M | -$31M | -$645K | -$13.3M | |
| Cash From Investing | $175.3M | -$25.5M | -$46M | -$71M | -$22.8M | |
| Cash From Financing | -$379K | $230K | -$1.4M | $83K | $17K | |
| Free Cash Flow | -$180.1M | $6.3M | -$31M | -$1.2M | -$13.3M | |
AMRN
Sector
Market Cap
$219.5M
$35.1M
Price % of 52-Week High
51.46%
44.56%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-41.76%
-40.62%
Beta (5-Year)
0.660
0.662
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$10.57
200-day SMA
Sell
Level
$11.09
Bollinger Bands (100)
Buy
Level
8.98 - 11.32
Chaikin Money Flow
Sell
Level
-20.2M
20-day SMA
Buy
Level
$9.99
Relative Strength Index (RSI14)
Buy
Level
52.20
ADX Line
Buy
Level
20.5
Williams %R
Neutral
Level
-33.8346
50-day SMA
Buy
Level
$9.62
MACD (12, 26)
Buy
Level
0.35
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Sell
Level
-863.9K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.1178)
Buy
CA Score
(Annual)
Level (0.0406)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.4974)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Stock Forecast FAQ
In the current month, AMRN has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AMRN average analyst price target in the past 3 months is $13.50.
-
Where Will Amarin Corp PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Amarin Corp PLC share price will rise to $13.50 per share over the next 12 months.
-
What Do Analysts Say About Amarin Corp PLC?
Analysts are divided on their view about Amarin Corp PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Amarin Corp PLC is a Sell and believe this share price will drop from its current level to $7.00.
-
What Is Amarin Corp PLC's Price Target?
The price target for Amarin Corp PLC over the next 1-year time period is forecast to be $13.50 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AMRN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Amarin Corp PLC is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of AMRN?
You can purchase shares of Amarin Corp PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Amarin Corp PLC shares.
-
What Is The Amarin Corp PLC Share Price Today?
Amarin Corp PLC was last trading at $10.19 per share. This represents the most recent stock quote for Amarin Corp PLC. Yesterday, Amarin Corp PLC closed at $10.19 per share.
-
How To Buy Amarin Corp PLC Stock Online?
In order to purchase Amarin Corp PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
